-
Barclays, Macquarie Upgrade Nielsen Holdings On Elliott Management Stake, Likelihood Of Sale
Tuesday, August 14, 2018 - 11:33am | 463Nielsen Holdings PLC (NYSE: NLSN) has endured fundamental changes, leading sell-side analysts to dissect the data company's future. The Analysts Barclays analyst Manav Patnaik upgraded Nielsen Holdings from Underweight to Equal Weight with a price target lifted from $21 to $27...
-
Barclays Recommends A Staffing Sector Pair Trade: Buy Robert Half, Sell ManpowerGroup
Tuesday, April 3, 2018 - 2:27pm | 490Robert Half International Inc. (NYSE: RHI) shares have appreciated 3.4 percent year-to-date period compared to a 9.8-percent drop in ManpowerGroup Inc. (NYSE: MAN), and this outperformance will continue, according to Barclays. The Analyst Analyst Manav Patnaik upgraded shares of...
-
So, What's The Next Move For Equifax?
Thursday, September 14, 2017 - 4:20pm | 329Equifax Inc. (NYSE: EFX)'s early response to one of the most devastating security breaches of all time has left plenty to be desired. The company’s lack of disaster control is sure to set up some tumultuous upcoming quarters. “With few (if any) positive catalysts, it is only prudent for...
-
Nord Anglia Education Investors Uneasy As Management's Execution Likely To Take Years
Thursday, October 13, 2016 - 3:04pm | 221Barclays maintained its Overweight rating on Nord Anglia Education Inc (NYSE: NORD) saying that investors need patience with the company to see returns. Though investing in the Chinese dual curriculum schools might be the right long-term decision, the brokerage said sizeable investment...
-
10 Beat And Raise Quarters In A Row For Cintas
Wednesday, September 28, 2016 - 4:06pm | 352A day after Cintas Corporation (NASDAQ: CTAS) delivered a beat and raise quarter for the tenth time in a row, Barclays reiterated its Overweight rating and $130 target price for the company's shares. This implied an over 12 percent upside potential from the current levels. Analyst Manav Patnaik...
-
Barclays Upgrades TransUnion, Hits Pause On Fair Isaac
Wednesday, September 21, 2016 - 10:53am | 376Barclays upgraded TransUnion (NYSE: TRU) shares from Equal Weight to Overweight, although there is no change in the price target of $37. However, analyst Manav Patnaik has downgraded Fair Isaac Corporation (NYSE: FICO) from Overweight to Equal Weight with a price tag of $135 on the stock. "...
-
Barclays Makes S&P Global A New Top Pick In Info Services Sector
Wednesday, September 21, 2016 - 10:41am | 331Barclays rates S&P Global Inc (NYSE: SPGI) as a new top pick in the information services sector. The comments came after analyst Manav Patnaik met S&P Global CEO Doug Peterson last week at a financials conference. As a result, Patnaik boosted the price target from $140 to $145 on the...
-
Barclays On TransUnion Earnings Beat: 'More Good Than Great'
Wednesday, July 27, 2016 - 3:12pm | 369Despite the solid second-quarter earnings beat and an upward adjustment to guidance, Barclays views the quarterly performance of TransUnion (NYSE: TRU) as "more 'good' than 'great.'" The muted opinion was attributed to the company's 2016 guidance raise coming in lighter than expected. Barclays...
-
Barclays Underwhelmed By Thomson Reuters' $1 Billion Share Buybacks
Tuesday, July 12, 2016 - 11:48am | 283Barclays expressed its disappointment over Thomson Reuters Corp (NYSE: TRI)'s $1 billion share buyback announcement that came along with its agreement to sell its intellectual property & science business to private equity funds affiliated with Onex Corporation and Baring Private Equity Asia for...
-
Credit Rating Agencies Could Feel An Immediate Impact From Brexit
Monday, June 27, 2016 - 10:13am | 304Credit issuance is typically negatively impacted by uncertainty, Barclays’ Manav Patnaik said in a report, while reducing the EUR issuance forecasts by ~20 percent on Brexit news. The analyst commented that Moody's Corporation (NYSE: MCO) and S&P Global Inc (NYSE: SPGI) are likely...
-
IMS Health May Buy AlphaImpactRX: What's It Mean?
Monday, December 28, 2015 - 11:03am | 233Barclays on Monday issued a report highlighting IMS Health Holdings Inc. (NYSE: IMS) and its potential acquisition of AlphaImpactRX. The report comes amid news of an FTC antitrust clearance notice. In the report, analysts Manav Patnaik and Eric Percher had several questions following news of...
-
Barclays Initiates TransUnion But Prefers Equifax, Fair Isaac And Experian
Monday, July 27, 2015 - 8:11am | 309In a report published Monday, Barclays analyst Manav Patnaik initiated coverage of TransUnion (NYSE: TRU) with an Equal-Weight rating and price target of $26. Although the analyst appreciate's the company's business model and leadership team, he prefers the stocks of Equifax, Inc. (NYSE:...
-
Barclays Sees Long-Term EPS Growth For Ecolab
Friday, January 9, 2015 - 1:23pm | 242Barclays commented on Ecolab Inc. (NYSE: ECL) Friday and maintained an Overweight rating while cutting its price target from $124 to $120. Analyst Manav Patnaik lowered the FY 2015 “estimates for ECL's Energy segment (30 percent of company) from 10.5 percent to a "worst case...
-
UPDATE: Barclays Initiates Coverage On Markit
Monday, July 14, 2014 - 12:32pm | 91In a research note released Monday, Barclays analyst Manav Patnaik initiated coverage on Markit (NASDAQ: MRKT) with an Equal-weight rating and a $30.00 price target. The analyst stated that Markit's unique position has made it a viable long-term stock. In addition, the company has...